Ameritas Investment Partners’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-7,236
| Closed | -$306K | – | 3277 |
|
|
2024
Q1 | $306K | Hold |
7,236
| – | – | 0.01% | 1018 |
|
|
2023
Q4 | $307K | Buy |
7,236
+1,088
| +18% | +$46.1K | 0.01% | 1015 |
|
|
2023
Q3 | $134K | Buy |
6,148
+1,038
| +20% | +$22.7K | 0.01% | 1449 |
|
|
2023
Q2 | $162K | Buy |
5,110
+526
| +11% | +$16.7K | 0.01% | 1263 |
|
|
2023
Q1 | $112K | Hold |
4,584
| – | – | ﹤0.01% | 1464 |
|
|
2022
Q4 | $149K | Buy |
4,584
+508
| +12% | +$16.5K | 0.01% | 1324 |
|
|
2022
Q3 | $115K | Hold |
4,076
| – | – | 0.01% | 1401 |
|
|
2022
Q2 | $107K | Buy |
4,076
+1,003
| +33% | +$26.3K | ﹤0.01% | 1466 |
|
|
2022
Q1 | $108K | Hold |
3,073
| – | – | ﹤0.01% | 1604 |
|
|
2021
Q4 | $100K | Hold |
3,073
| – | – | ﹤0.01% | 1686 |
|
|
2021
Q3 | $91K | Buy |
3,073
+308
| +11% | +$9.12K | ﹤0.01% | 1755 |
|
|
2021
Q2 | $71K | Buy |
+2,765
| New | +$71K | ﹤0.01% | 1954 |
|